Medtech stocks hurt by overall market slide
The five Singapore-listed stocks that are part of the industry have generated an average one-year total return of minus 10%
Singapore
THE medtech industry, as represented by the listed stocks on the Singapore Exchange (SGX), has been hurt by market volatility despite the bubbling prospects of the sector.
The five Singapore-listed stocks that are part of the healthcare equipment and supplies industry, which now include the latest medtech listing Biolidics have generated an average one-year total return of negative 10 per cent. This, however, is in line with the total one-year return of about negative 10.5 per cent of the Straits Times Index, data from Bloomberg showed.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
EU toughens rules on Chinese fashion retailer Shein
Keppel prices 70 million euros of floating-rate notes due 2031
Mixed trading in Asia as investors watch for further macro data; STI down 0.2%
Shareholders raise questions over dividend payout, directors’ salaries at Best World AGM ahead of proposed privatisation
China’s Bank of Communications Q1 profit rises 1.44%
Huawei’s smart car tech offers automakers route to China sales